Document details

T790M-EGFR mutation frequency in advanced NSCLC patients on progression from a previous TKI therapy: results from a Portuguese study

Author(s): Teixeira, E ; Araújo, A ; Hespanhol, V ; Parente, B ; Barata, F

Date: 2021

Persistent ID: http://hdl.handle.net/10400.26/37675

Origin: Saúde - CUF

Subject(s): Carcinoma do Pulmão de Células não Pequenas; Resistencia a Medicamentos Antineoplásicos; Receptor ErbB-2; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; ErbB Receptors


Document Type Journal article
Language English
Contributor(s) Repositório Comum
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents